Beijing Zhongshuo Pharmaceutical Technology Development Co. Ltd.
Trading Company

地址:2 floor NPCPI, No.16, 7 Area, Hepingli, Dongcheng District, Beijing, P.R.China China (Mainland) chaoyang beijing

主营产品:

主要市场:North America South America Southeast Asia Mid East

业务范围:?Paclitaxel, Docetaxel, Cabazitaxel, Oxaliplatin, Fulvestrant, Bortezomib, Doxorubicin Hydrochloride, Pemetrexed Disodium Hemipenta Hydrate, 5-Fluorouracil, Irinotecan Hydrochloride Trihydrate, Granisetron Hydrochloride;

注册资本: 1000000

公司规模:11 - 50People

成立年份:lismallBusiness Type:/smallspan class=pro2 Trading Company

法人代表:lily.huilian

lily.huilian

86-010-6443062613426487794

1334208816@qq.com

www.chinazhongshuo.com

Beijing Zhongshuo Pharmaceutical Technology Development Co. Ltd. (BJ Zhongshuo) was established in 2001. Its former is a state-owned enterprise found by CNPIC of SINOPHARM. After business restructuring, it is now a rapid developing joint-stock enterprise.
The sales centre of BJ Zhongshuo is located in Beijing, and responsible for selling specialized APIs and pharmaceutical intermediates both domestically and overseas. The business of BJ Zhongshuo covers more than 200 products, including the APIs and pharmaceutical intermediates related to Antivirus, Antineoplastics, Cardiovascular agents, Central Nervous System and Antibiotics, etc.